IGF2BP2 and lung carcinoma: m6A readers from the IGF2BPs family showed high expression levels and mutation frequency, especially IGF2BP2. According to Li et al., IGF2BP2 and IGF2BP3 was essential for lung cancer progression, and they could identify and stabilize m6A sites and function as ‘readers’ in the post-transcriptional regulation manner (34).